Stay up-to-date with the latest developments in securities law through access to both news and all statutes and regulations. Find relevant corporate filings through a searchable EDGAR database. And...
Johnson & Johnson is facing what may be its first investor class action stemming from allegations the company knew as far back as the 1970s that asbestos fibers in its talc products could cause cancer.
Investors suffered losses when the price of J&J’s stock dropped after reports surfaced that the company knew decades ago that asbestos fibers in its talc products could cause certain cancers, according to a Feb. 8 complaint filed in the U.S. District Court for the District of New Jersey.
J&J is fighting thousands of consumer lawsuits over the alleged link between its talc products—including baby powder—and ovarian cancer and mesothelioma, with mixed results in the courts. The investors’ complaint claims the company misled them about the decades-old link, repeatedly saying its talc products were asbestos-free and safe.
J&J’s vice president of media relations, Ernie Knewitz, described the lawsuit as “baseless,” saying the company will vigorously defend its position. Similar allegations regarding asbestos “were soundly rejected by a California jury in November 2017,” he told Bloomberg Law in an email.
“Johnson’s Baby Powder does not contain asbestos or cause mesothelioma or ovarian cancer, and we are confident that our talc products are, and always have been, free of asbestos, based on decades of monitoring, testing and regulation dating back to the 1970s,” Knewitz said. “Sample testing by independent laboratories, independent scientists, governmental agencies, and academic institutions spanning decades have all confirmed the absence of asbestos in our talc products.”
A New Jersey state court previously dismissed some consumer cases against J&J for lack of valid scientific evidence. Juries in other states have awarded millions of dollars in damages to plaintiffs alleging J&J’s talc products caused their cancer.
The investors’ allegations are based on a document revealed during one of the consumer lawsuits. The document showed J&J marketed its talc products as asbestos-free despite knowing in the early 1970s that asbestos might have been present at some of its talc mines, according to the complaint.
J&J stock dropped $2.28 per share after Bloomberg reported on the document in September 2017, according to the complaint.
The case is Hall v. Johnson & Johnson , D.N.J., No. 3:18-cv-01833, complaint filed 2/8/18 .
To contact the reporter on this story: Jennifer Bennett in Washington at email@example.com
To contact the editor responsible for this story: Seth Stern at firstname.lastname@example.org
Copyright © 2018 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)